Wizbiotech Obtains 10 NMPA Certifications
On the journey of pursuing excellence and innovation, Wizbiotech is moving forward with solid steps. Recently, 10 in vitro diagnostic test kits have successfully obtained approval from the Fujian Provincial Drug Administration. The 10 products approved this time cover a number of important medical fields, including thyroid function, cardiovascular disease, reproductive health, and diabetes management, demonstrating the deep strength and unremitting pursuit of Wizbiotech in the field of precision medicine.
The research and development of these reagents not only reflects the ultimate pursuit of technological innovation and product quality for Wizbiotech, but also demonstrates our company's firm commitment to "focusing on diagnostic technology to improve quality of life". Through cutting-edge biotechnology, we have ensured the excellent performance of these reagents in terms of detection accuracy and reliability, providing solid support for clinical diagnosis and further consolidating our company's core position in the industry.
With the launch of these products, Xiamen Wiz Biotech Co., Ltd. will be able to provide more diverse and comprehensive diagnostic services to patients, helping doctors make more accurate treatment decisions, significantly improving the treatment effectiveness of patients, and bringing higher efficiency and economic benefits to the medical system.
